Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1663-1672
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1663
Table 4 Odds ratios for 30-day postoperative complications for patients with adenocarcinoma of the pancreas undergoing a pancreaticoduodenectomy from 2015 to 2019
Complication
Neoadjuvant radiotherapy crude OR (95%CI)
Crude P value
Neoadjuvant radiotherapy adjusted OR/IRR (95%CI)
Adjusted P value
Total operative time 0.15 (0.13, 0.16)< 0.001a1.14 (1.11,1.16)1< 0.001a
Perioperative transfusion1.49 (1.32, 1.69)< 0.001a1.58 (1.37, 1.82)2< 0.001a
Superficial SSI1.13 (0.93, 1.38)0.217NPNP
Organ space SSI0.76 (0.63, 0.91)0.004a0.80 (0.66, 0.97)30.020a
30-d reoperation1.03 (0.80, 1.32)0.832NPNP
30-d mortality rate0.40 (0.21, 0.75)0.005aNPNP
30-d readmission rate1.14 (0.98, 1.32)0.090NPNP
Renal failure0.74 (0.37, 1.47)0.382NPNP
Total hospital stay0.09 (0.06, 0.12)< 0.001a0.99 (0.96, 1.02)40.640
Drain in place on POD 300.76 (0.61, 0.99)0.041a0.82 (0.64, 1.06)50.124
Pancreatic fistula0.47 (0.38, 0.58)< 0.001a0.50 (0.40, 0.63)5< 0.001a
Delayed gastric emptying0.81 (0.69, 0.95)0.010a0.86 (0.72, 1.01)50.073